Regulatory watch: Efficiency indicators for new drugs approved by the FDA from 2003 to 2013

Nat Rev Drug Discov. 2015 Mar;14(3):156. doi: 10.1038/nrd4563.

Authors

Rossella Belleli¹, Roland Fisch¹, Thomas D Szucs²

Affiliations

¹ Novartis Pharma AG Postfach CH-4002 Basel, Switzerland.
² European Center of Pharmaceutical Medicine/Institute of Pharmaceutical Medicine, University of Basel, Klingelbergstrasse 61 CH-4056 Basel, Switzerland.

PMID: 25722232
DOI: 10.1038/nrd4563

No abstract available

Publication types

News

MeSH terms

Biological Products
Drug Approval / statistics & numerical data*
Pharmaceutical Preparations / standards*
Treatment Outcome*
United States
United States Food and Drug Administration

Substances

Biological Products
Pharmaceutical Preparations